Abstract: FR-PO355
Effect of Coronary Revascularization on the Association of Elevated Troponin with Post-Dialysis Mortality in Patients with Advanced CKD
Session Information
- Hypertension and CVD: Clinical, Outcomes, Trials
October 26, 2018 | Location: Exhibit Hall, San Diego Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Hypertension and CVD
- 1402 Hypertension and CVD: Clinical, Outcomes, and Trials
Authors
- Koshy, Santhosh K., Regional One Health - University of TN Health Sciences Ctr, Memphis, Tennessee, United States
- George, Lekha K., University of Tennessee Health Science Center, Memphis, Tennessee, United States
- Molnar, Miklos Zsolt, University of Tennessee Health Science Center, Memphis, Tennessee, United States
- Potukuchi, Praveen Kumar, University of Tennessee Health Science Center, Memphis, Tennessee, United States
- Gaipov, Abduzhappar, University of Tennessee Health Science Center, Memphis, Tennessee, United States
- Agarwal, Manyoo, University of Tennessee Health Science Center, Memphis, Tennessee, United States
- George, Koshy K., University of Queensland, Memphis, Tennessee, United States
- Kalantar-Zadeh, Kamyar, University of California Irvine, School of Medicine, Orange, California, United States
- Kovesdy, Csaba P., Memphis VA Medical Center, Memphis, Tennessee, United States
Background
Coronary revascularization (CR), supported by its long-term mortality benefit, is indicated for high risk acute coronary syndrome as evidenced by elevated troponin. Patients with CKD often present with higher and sustained levels of troponin due to reduced clearance, causing diagnostic uncertainty and potentially resulting in fewer patients receiving CR. The incidence of CR and its benefits on long-term mortality in patients with advanced CKD and elevated troponin levels is unclear.
Methods
We examined 16,759 US veterans who had troponin measured during the 3 years prior to start of dialysis. We examined the association between troponin level and future CR, and whether or not future CR modifies the association between troponin levels and subsequent mortality. We modelled the risk of mortality associated with the highest recorded troponin level in time-dependent Cox models including the interaction between troponin and future CR, while adjusting for demographics, comorbidities, smoking status, blood pressure, BMI and baseline eGFR.
Results
Patients were 66±10 years old, 97% male, 37% African-American and 77% diabetic. CR was performed in only 326 patients (2%) following a troponin measurement, and higher troponin was associated with future CR (multivariable adjusted hazard ratio and 95%CI in fourth [>0.25 ng/ml] vs. first quartile [<0.03 ng/ml] of troponin: 6.35 [4.26-9.46]). Death occurred in 11,315 patients (67%). Higher troponin was associated with linearly higher mortality in patients who did not undergo CR (Figure). Patients who underwent CR experienced numerically lower risk of death associated with troponin levels compared to those without CR (Figure), but the interaction was not statistically significant.
Conclusion
CR may be associated with lower post-dialysis mortality in patients with advanced CKD and elevated troponin. The potential benefit of CR in this population needs to be explored further in large prospective studies.
Funding
- NIDDK Support